Ventricular Arrhythmias: Mechanisms and Management
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Electrophysiology and Cardiovascular Physiology".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 24
Special Issue Editor
Interests: artificial intelligence; machine learning; cardiac electrophysiology; predictive modeling; personalized medicine; signal analysis; big data; supervised learning; unsupervised learning
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ventricular arrhythmias (VAs) continue to present a formidable challenge, especially among patients with structural heart disease, inherited arrhythmia syndromes, or heart failure. This Special Issue is dedicated to exploring the complex mechanisms behind ventricular tachycardia (VT) and ventricular fibrillation (VF) while showcasing recent advances in both diagnostic tools and therapeutic strategies. Innovations such as pulse field ablation, novel mapping strategies, functional imaging, and the integration of artificial intelligence are reshaping our approach to identifying arrhythmic substrates.
We invite manuscripts that address the full spectrum of emerging therapies in the management of ventricular arrhythmias and heart failure. We welcome studies on state-of-the-art device therapies, including implantable cardioverter-defibrillators (ICDs), subcutaneous ICDs, biventricular pacing, conduction system pacing, cardiac contraction modulation (CCM), and Barostim. We also seek contributions on advanced ablation techniques—from epicardial and complex VT ablation to innovative strategies and targets such as pulse field ablation and radiotherapy—with a particular interest in clinical studies evaluating ablation outcomes in heart failure patients. Additionally, research focusing on premature ventricular contractions (PVCs), autonomic modulation, strategies to prevent heart failure and VT, and interventions designed to improve cardiac function is encouraged. Finally, manuscripts exploring the impact of breakthrough medical therapies, including SGLT2 inhibitors and GLP1 receptor agonists, on arrhythmia management and cardiac performance are highly welcome. With these explosive advances, there has never been a more opportune time to focus on this dynamic and rapidly evolving field.
Dr. Faisal F. Syed
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- arrhythmia mechanisms
- risk prediction
- ventricular tachycardia
- premature ventricular complex
- ventricular fibrillation
- catheter ablation
- heart failure device therapies
- autonomic modulation
- GLP-1 agonists
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
